Related references
Note: Only part of the references are listed.Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China
Weier Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Cardiovascular manifestations and treatment considerations in COVID-19
Yu Kang et al.
HEART (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review)
Daniela Calina et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence
Aristidis Tsatsakis et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms
Manuela Pennisi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
Konstantinos Farsalinos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Scalable molecular dynamics on CPU and GPU architectures with NAMD
James C. Phillips et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis
Diana C. Sanchez-Ramirez et al.
RESPIRATORY MEDICINE (2020)
COVID-19 vaccines: ethical framework concerning human challenge studies
Daniela Calina et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient
Meret Huber et al.
FRONTIERS IN NEUROLOGY (2020)
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
Aristides Tsatsakis et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis
Askin Guelsen et al.
PULMONARY MEDICINE (2020)
Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
Ronald N. Kostoff et al.
TOXICOLOGY REPORTS (2020)
Performance of HADDOCK and a simple contact-based protein-ligand binding affinity predictor in the D3R Grand Challenge 2
Zeynep Kurkcuoglu et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2018)
Expression and Function of the Cholinergic System in Immune Cells
Takeshi Fujii et al.
FRONTIERS IN IMMUNOLOGY (2017)
Protocols for Molecular Modeling with Rosetta3 and RosettaScripts
Brian J. Bender et al.
BIOCHEMISTRY (2016)
PRODIGY: a web server for predicting the binding affinity of protein-protein complexes
Li C. Xue et al.
BIOINFORMATICS (2016)
Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3
Ge Li-Sha et al.
SCIENTIFIC REPORTS (2015)
Protective Role of the Cholinergic Anti-Inflammatory Pathway in a Mouse Model of Viral Myocarditis
Zheng Cheng et al.
PLOS ONE (2014)
Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera
Sun Huang et al.
BIOCHEMICAL JOURNAL (2013)
NMR-based insights into the conformational and interaction properties of Arkadia RING-H2 E3 Ub ligase
Christos T. Chasapis et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2012)
SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules
Vincent Zoete et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
Shaheen E. Lakhan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Jesus F. Bermejo-Martin et al.
CRITICAL CARE (2009)
Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice
Yann S. Mineur et al.
NEUROPHARMACOLOGY (2007)
Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases
David A. Scott et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors
Karla B. Mihalak et al.
MOLECULAR PHARMACOLOGY (2006)
Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine
M Jonsson et al.
ANESTHESIOLOGY (2006)
The role of nicotinic acetylcholine receptors in lymphocyte development
M Skok et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
The vagus nerve and the nicotinic anti-inflammatory pathway
L Ulloa
NATURE REVIEWS DRUG DISCOVERY (2005)
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
WJ de Jonge et al.
NATURE IMMUNOLOGY (2005)
Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation
RW Saeed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Software extensions to UCSF Chimera for interactive visualization of large molecular assemblies
TD Goddard et al.
STRUCTURE (2005)
Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells
LC Gahring et al.
AAPS JOURNAL (2005)
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
H Wang et al.
NATURE MEDICINE (2004)
Efferent vagal fibre stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock (Publication with Expression of Concern. See vol. 146, 2022)
S Guarini et al.
CIRCULATION (2003)
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
H Wang et al.
NATURE (2003)
Nicotinic receptor signaling in nonexcitable cells
G Sharma et al.
JOURNAL OF NEUROBIOLOGY (2002)
The metabolism and excretion of galantamine in rats, dogs, and humans
GSJ Mannens et al.
DRUG METABOLISM AND DISPOSITION (2002)
Share Paper
